CQDM - News

ABOUT
PROGRAMS
FUNDED PROJECTS
NEWS
Contact
FR
Events

ABOUT
PROGRAMS
FUNDED PROJECTS
NEWS
Contact
FR
Events

Our Latest News

JOB OFFER – ADMINISTRATIVE ASSISTANT
6 October 2022
CQDM nominates John Delaney and Jennifer Hamilton as Scientific Advisory Board members
29 August 2022
JOB OFFER – SENIOR DIRECTOR ACCOUNTING AND FINANCE
29 August 2022
CQDM, the Quebec Breast Cancer Foundation and Theratechnologies fund close to $2 million for research project to validate the anti-metastatic potential of TH1902 at the Université du Québec à Montréal
12 July 2022
CQDM and SPM Therapeutics fund a study carried out by Professor Boilard at the CHU de Québec-Université Laval to develop a treatment for systemic lupus erythematosus
16 June 2022
(FR) Stratégie québécoise de recherche et d’investissement en innovation 2022-2027
19 May 2022
(FR) Le CQDM accueille favorablement la mise à jour de la Stratégie québécoise des sciences de la vie
12 May 2022
Make a difference! Job Opportunity: controller
2 May 2022
CQDM funds an innovative project with Altus Formulation and Tetra Bio-Pharma to develop first-in-class treatments for ocular inflammation
26 April 2022
CQDM and NanoGene Therapeutics Fund the Development of a Treatment for Psoriasis
9 March 2022
SAVE THE DATE / Bio+ech Connec+ event taking place on Wednesday March 16th
2 March 2022
Le CQDM s’associe à Neurasic Therapeutics, CSVS et la Fondation Louise et Alan Edwards pour financer le développement d’un analgésique non opiacé
12 January 2022
Le CQDM félicite les récipiendaires du deuxième appel de projets du Fonds d’accélération des collaborations en santé (FACS)
14 December 2021
CQDM funds a project to improve the screening of lung cancer with BioMark Diagnostic Solutions, in partnership with AstraZeneca, Pfizer Canada and the IUCPQ Foundation
29 November 2021
ADRIQ* 2021 AWARD – CQDM congratulates Feldan Therapeutics for receiving the 2021 ADRIQ RSRI (regroupements sectoriels de recherche industrielle) award.
25 November 2021
2021 Sweet Pharma Day Winner is HDAX Therapeutics
8 October 2021
A new partnership between CQDM, the Canadian Cancer Society, the Cole Foundation and Oncopole to support pediatric cancer research
7 October 2021
CQDM invests in Montreal-based regenerative medicine company, Morphocell Technologies
7 July 2021
CQDM invests $500,000 in Giiant Pharma, a Quebec-based pharmaceutical company with strong potential in gastroenterology
30 June 2021
CQDM to fund an international collaboration between Raya Therapeutic, Eikonizo Therapeutics and McGill University
20 June 2021
CQDM sets up a collaboration between Simon Fraser University, Amgen, Merck, Servier and GlycoNet
2 June 2021
Accélérer le passage de l’idée au marché – Dépôt du mémoire des RSRI
31 May 2021
CQDM, MEDTEQ+ and Montréal InVivo partner with IVADO to promote digital health innovation
11 May 2021
CQDM appoints Brian Underdown as the Chair of its Scientific Advisory Board (SAB) and nominates 3 new SAB members
28 April 2021
48Hour Discovery and Merck initiate drug discovery project – Project funded through CQDM Quantum Leap program
15 March 2021
CQDM to fund an international collaboration between Traffick Therapeutics, McGill University and the Lead Discovery Center
24 February 2021
Pre-budget Consultations: 3 proposals from CQDM to boost Quebec’s economy
26 January 2021
Le soutien à l’innovation est essentiel pour notre prospérité
8 December 2020
CQDM is proud to contribute to the success of Medicago and its partners, winners of the 2020 RSRI Innovation Award from ADRIQ
19 November 2020
CQDM portfolio company Mesentech secures new capital to bring lead product to clinical phase
11 November 2020
CQDM funds the development of a novel artificial intelligence tool for cardiovascular clinical trials
5 November 2020
Philip Tagari Appointed to CQDM’s Board of Directors
5 October 2020
CQDM Awards a Grant to Centre de Recherche du CHU de Québec-Université Laval …
20 July 2020
nplex-McGill partnership selected by CQDM for a $1M grant to apply next-generation ELISA in drug discovery
16 July 2020
CQDM announces funding to develop a test to predict disease progression in patients infected with COVID-19
14 July 2020
CQDM becomes a shareholder of Mesentech to support the validation of a highly promising bone-targeting drug delivery technology
22 June 2020
Health Innovation: Investing Now to Face the Crises of Tomorrow
20 June 2020
The Canadian Cancer Society, the Quebec Breast Cancer Foundation and CQDM join forces to fight breast cancer
18 June 2020
CQDM grants $1.15 M in funding to Professor Yves St-Pierre’s team to develop a revolutionary immunotherapy against breast cancer
18 June 2020
New call for proposals under the Fonds d’accélération des collaborations en santé
16 June 2020
Mobilisation sans précédent de l’écosystème québécois de recherche et d’innovation contre la COVID-19
19 May 2020
Theratechnologies Unveils New Positive Data For Its Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Cancers
15 May 2020
Collaborative project of more than $1.2 million using artificial intelligence to optimize the production of vaccines, announced by CQDM and Medicago R&D
5 May 2020
Pre-launch of a new call for proposals in June 2020: discover the latest updates!
27 April 2020
CQDM welcomes Zymeworks as a new member of CQDM’s biopharmaceutical consortium
27 February 2020
CQDM partners with GlycoNet to support innovative Glycomics research in Canada
25 February 2020
2nd Annual Gordon Shore Prize – Postdoctoral Internships in the Biopharmaceutical Industry
17 February 2020
Project funded through CQDM will explore potential of Fusion Genomics’ ONETest™ to improve diagnosis of respiratory tract infections
9 January 2020
Postponed deadline to submit a SynergiQc project
1 January 2020
CQDM and the Canadian Cancer Society commend Theratechnologies and UQAM for their success in developing a new therapy against the most aggressive form of breast cancer
18 December 2019

Annual Archive

2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008

About CQDM

Mission, Vision and Value Proposition
Structure & Governance
Team
Members
Collaborators
Contact us

Programs

Quantum Leap
SynergiQc
PARTENAR-IA | ENTREPRISE
FACS – Fonds d’accélération des collaborations en santé
SynergiQc-International
Mentorship
Completed Programs

Follow Us!

Tweets by @CQDM_Canada

© CQDM 2020 // Web: Draxo Marketing

Nous utilisons des témoins (cookies) et d'autres technologies de suivi pour améliorer votre expérience de navigation sur notre site Web. En naviguant sur notre site Web, vous consentez à ce que nous utilisions des témoins (cookies) et d'autres technologies de suivi. Accepter

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT